Martina Brueckmann
1st Department of Medicine
Faculty of Clinical Medicine Mannheim
University of Heidelberg
Mannheim
Germany
[email]@med.ma.uni-heidelberg.de
Name/email consistency: high
- Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer. Brueckmann, M., Borggrefe, M. Gut (2007)
- Prognostic value of platelet-derived growth factor in patients with severe sepsis. Brueckmann, M., Hoffmann, U., Engelhardt, C., Lang, S., Fukudome, K., Haase, K.K., Liebe, V., Kaden, J.J., Putensen, C., Borggrefe, M., Huhle, G. Growth. Factors (2007)
- Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells. Brueckmann, M., Nahrup, A.S., Lang, S., Bertsch, T., Fukudome, K., Liebe, V., Kaden, J.J., Hoffmann, U., Borggrefe, M., Huhle, G. Br. J. Haematol. (2006)
- Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1. Brueckmann, M., Horn, S., Lang, S., Fukudome, K., Schulze Nahrup, A., Hoffmann, U., Kaden, J.J., Borggrefe, M., Haase, K.K., Huhle, G. Thromb. Haemost. (2005)
- Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes. Brueckmann, M., Hoffmann, U., De Rossi, L., Weiler, H.M., Liebe, V., Lang, S., Kaden, J.J., Borggrefe, M., Haase, K.K., Huhle, G. Cytokine (2004)
- Markers of myocardial damage, tissue healing, and inflammation after radiofrequency catheter ablation of atrial tachyarrhythmias. Brueckmann, M., Wolpert, C., Bertsch, T., Sueselbeck, T., Liebetrau, C., Kaden, J.J., Huhle, G., Neumaier, M., Borggrefe, M., Haase, K.K. J. Cardiovasc. Electrophysiol. (2004)
- N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias. Brueckmann, M., Bertsch, T., Hoffmann, U., Lang, S., Kaden, J.J., Wolpert, C., Huhle, G., Borggrefe, M., Haase, K.K. Clin. Chem. Lab. Med. (2004)
- Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Brueckmann, M., Bertsch, T., Lang, S., Sueselbeck, T., Wolpert, C., Kaden, J.J., Jaramillo, C., Huhle, G., Borggrefe, M., Haase, K.K. Clin. Chem. Lab. Med. (2004)
- Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Brueckmann, M., Hoffmann, U., Dvortsak, E., Lang, S., Kaden, J.J., Borggrefe, M., Haase, K.K. Inflamm. Res. (2004)
- Stabilization of monocyte chemoattractant protein-1-mRNA by activated protein C. Brueckmann, M., Marx, A., Weiler, H.M., Liebe, V., Lang, S., Kaden, J.J., Zieger, W., Borggrefe, M., Huhle, G., Konstantin Haase, K. Thromb. Haemost. (2003)
- Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure. Brueckmann, M., Wizenmann, J., Hoffmann, U., Seeger, M., Bewig, B. Thromb. Res. (2003)
